Skip to main content
Erschienen in: International Urology and Nephrology 4/2023

19.12.2022 | Urology - Original Paper

Efficacy of a novel wearable transcutaneous tibial nerve stimulation device on bladder reflex compared to implantable tibial nerve stimulation in cats

verfasst von: Xunhua Li, Zhonghan Zhou, Hui Zhao, Limin Liao, Xing Li

Erschienen in: International Urology and Nephrology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the efficacy of novel wearable transcutaneous tibial nerve stimulation (TTNS) device on bladder reflex in cats compared to implantable tibial nerve stimulation (ITNS).

Materials and methods

Two self-adhesive electrodes of the TTNS device were placed at the left leg, and ITNS was applied to stimulate the tibial nerve of the right leg, respectively. The intensity threshold (T) was defined as inducing observable toe movement. Multiple cystometrograms (CMGs) with normal saline (NS) infusion were performed to determine the inhibitory effects of TTNS and ITNS on the micturition reflex.

Results

TTNS at 4 times T (4 T), 6 times T (6 T), and the maximum output current intensity 24 mA significantly increased the bladder capacity (BC) compared to the control level (8.70 ± 2.46 ml) (all p < 0.05); however, there was no statistical significance among the three intensities. At the same time, ITNS at 2 times T (2 T), 4 T, 6 T, and the current intension 24 mA could significantly increase the BC compared to the control level (all p < 0.05). Likewise, no significant difference was observed among the four intensities (p > 0.05). The T values of TTNS were higher than those of ITNS (p = 0.02). The inhibitory effects of TTNS and ITNS revealed no significant difference at their respective 2 T, 4 T, 6 T, and 24 mA. Neither TTNS nor ITNS changed the contraction duration and amplitude (all p > 0.05).

Conclusions

TTNS was effective in increasing BC. The non-invasive neuromodulation technique could achieve a similar effect as ITNS.
Literatur
1.
Zurück zum Zitat Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26CrossRefPubMed Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26CrossRefPubMed
2.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 21(2):167–178CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 21(2):167–178CrossRefPubMed
3.
Zurück zum Zitat van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama a Nijholt AA, Siegel S, Jonas U et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178(5):2029–2034CrossRefPubMed van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama a Nijholt AA, Siegel S, Jonas U et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178(5):2029–2034CrossRefPubMed
4.
Zurück zum Zitat Rapp DE, Lucioni A, Katz EE, O’Connor RC, Gerber GS, Bales GT (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63(6):1071–1075CrossRefPubMed Rapp DE, Lucioni A, Katz EE, O’Connor RC, Gerber GS, Bales GT (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63(6):1071–1075CrossRefPubMed
5.
Zurück zum Zitat Schneider MP, Gross T, Bachmann LM, Blok BF, Castro-Diaz D, Del Popolo G et al (2015) Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol 68(5):859–867CrossRefPubMed Schneider MP, Gross T, Bachmann LM, Blok BF, Castro-Diaz D, Del Popolo G et al (2015) Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol 68(5):859–867CrossRefPubMed
6.
Zurück zum Zitat Te Dorsthorst M, van Balken M, Heesakkers J (2020) Tibial nerve stimulation in the treatment of overactive bladder syndrome: technical features of latest applications. Curr Opin Urol 30(4):513–518CrossRef Te Dorsthorst M, van Balken M, Heesakkers J (2020) Tibial nerve stimulation in the treatment of overactive bladder syndrome: technical features of latest applications. Curr Opin Urol 30(4):513–518CrossRef
7.
Zurück zum Zitat Martin-Garcia M, Crampton J (2019) A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Physiotherapy 105(4):469–475CrossRefPubMed Martin-Garcia M, Crampton J (2019) A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Physiotherapy 105(4):469–475CrossRefPubMed
8.
Zurück zum Zitat Ramirez-Garcia I, Blanco-Ratto L, Kauffmann S, Carralero-Martinez A, Sanchez E (2019) Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial. Neurourol Urodyn 38(1):261–268CrossRefPubMed Ramirez-Garcia I, Blanco-Ratto L, Kauffmann S, Carralero-Martinez A, Sanchez E (2019) Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial. Neurourol Urodyn 38(1):261–268CrossRefPubMed
9.
Zurück zum Zitat Shapiro K, Pace N, Morgan T, Cai H, Shen B, Wang J et al (2020) Additive inhibition of reflex bladder activity induced by bilateral pudendal neuromodulation in cats. Front Neurosci 14:80CrossRefPubMedPubMedCentral Shapiro K, Pace N, Morgan T, Cai H, Shen B, Wang J et al (2020) Additive inhibition of reflex bladder activity induced by bilateral pudendal neuromodulation in cats. Front Neurosci 14:80CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ammi M, Chautard D, Brassart E, Culty T, Azzouzi AR, Bigot P (2014) Transcutaneous posterior tibial nerve stimulation: evaluation of a therapeutic option in the management of anticholinergic refractory overactive bladder. Int Urogynecol J 25(8):1065–1069CrossRefPubMed Ammi M, Chautard D, Brassart E, Culty T, Azzouzi AR, Bigot P (2014) Transcutaneous posterior tibial nerve stimulation: evaluation of a therapeutic option in the management of anticholinergic refractory overactive bladder. Int Urogynecol J 25(8):1065–1069CrossRefPubMed
11.
Zurück zum Zitat Moazzam Z, Duke AR, Yoo PB (2016) Inhibition and excitation of bladder function by tibial nerve stimulation using a wirelessly powered implant: an acute study in anesthetized cats. J Urol 196(3):926–933CrossRefPubMed Moazzam Z, Duke AR, Yoo PB (2016) Inhibition and excitation of bladder function by tibial nerve stimulation using a wirelessly powered implant: an acute study in anesthetized cats. J Urol 196(3):926–933CrossRefPubMed
12.
Zurück zum Zitat van Breda HMK, Martens FMJ, Tromp J, Heesakkers J (2017) A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol 198(1):205–210CrossRefPubMed van Breda HMK, Martens FMJ, Tromp J, Heesakkers J (2017) A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol 198(1):205–210CrossRefPubMed
13.
Zurück zum Zitat Theisen K, Browning J, Li X, Li S, Shen B, Wang J et al (2018) Frequency dependent tibial neuromodulation of bladder underactivity and overactivity in cats. Neuromodulation 21(7):700–706CrossRefPubMedPubMedCentral Theisen K, Browning J, Li X, Li S, Shen B, Wang J et al (2018) Frequency dependent tibial neuromodulation of bladder underactivity and overactivity in cats. Neuromodulation 21(7):700–706CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Andersen K, Kobbero H, Pedersen TB, Poulsen MH (2021) Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience. Scand J Urol 55(2):169–176CrossRefPubMed Andersen K, Kobbero H, Pedersen TB, Poulsen MH (2021) Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience. Scand J Urol 55(2):169–176CrossRefPubMed
15.
Zurück zum Zitat Araujo TG, Schmidt AP, Sanches PRS, Silva Junior DP, Rieder CRM, Ramos JGL (2021) Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson’s disease: a randomized clinical trial. Neurourol Urodyn 40(1):538–548CrossRefPubMed Araujo TG, Schmidt AP, Sanches PRS, Silva Junior DP, Rieder CRM, Ramos JGL (2021) Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson’s disease: a randomized clinical trial. Neurourol Urodyn 40(1):538–548CrossRefPubMed
16.
Zurück zum Zitat Li S, Browning J, Theisen K, Yecies T, Shen B, Wang J et al (2020) Prolonged nonobstructive urinary retention induced by tibial nerve stimulation in cats. Am J Physiol Regul Integr Comp Physiol 318(2):R428–R434 CrossRefPubMedPubMedCentral Li S, Browning J, Theisen K, Yecies T, Shen B, Wang J et al (2020) Prolonged nonobstructive urinary retention induced by tibial nerve stimulation in cats. Am J Physiol Regul Integr Comp Physiol 318(2):R428–R434 CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat MS Alomari, AS Abdulhamid, AA Ghaddaf, KM Alshareef, AK Haneef, MS AlQuhaibi, RA Banjar (2022) Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis. Int J Urol 29(10):1170–1180 MS Alomari, AS Abdulhamid, AA Ghaddaf, KM Alshareef, AK Haneef, MS AlQuhaibi, RA Banjar (2022) Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis. Int J Urol 29(10):1170–1180
18.
Zurück zum Zitat Tucker A, Maass A, Bain D, Chen LH, Azzam M, Dawson H et al (2010) Augmentation of venous, arterial and microvascular blood supply in the leg by isometric neuromuscular stimulation via the peroneal nerve. Int J Angiol 19(1):e31–e37CrossRefPubMedPubMedCentral Tucker A, Maass A, Bain D, Chen LH, Azzam M, Dawson H et al (2010) Augmentation of venous, arterial and microvascular blood supply in the leg by isometric neuromuscular stimulation via the peroneal nerve. Int J Angiol 19(1):e31–e37CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Sato A, Sato Y, Schmidt RF (1980) Reflex bladder activity induced by electrical stimulation of hind limb somatic afferents in the cat. J Auton Nerv Syst 1(3):229–241CrossRefPubMed Sato A, Sato Y, Schmidt RF (1980) Reflex bladder activity induced by electrical stimulation of hind limb somatic afferents in the cat. J Auton Nerv Syst 1(3):229–241CrossRefPubMed
20.
Zurück zum Zitat Kovacevic M, Yoo PB (2015) Reflex neuromodulation of bladder function elicited by posterior tibial nerve stimulation in anesthetized rats. Am J Physiol Renal Physiol 308(4):F320–F329CrossRefPubMed Kovacevic M, Yoo PB (2015) Reflex neuromodulation of bladder function elicited by posterior tibial nerve stimulation in anesthetized rats. Am J Physiol Renal Physiol 308(4):F320–F329CrossRefPubMed
21.
Zurück zum Zitat Wang Z, Liao L, Deng H, Li X, Chen G, Liao X (2018) The different roles of opioid receptors in the inhibitory effects induced by sacral dorsal root ganglion stimulation on nociceptive and nonnociceptive conditions in cats. Neurourol Urodyn 37(8):2462–2469CrossRefPubMed Wang Z, Liao L, Deng H, Li X, Chen G, Liao X (2018) The different roles of opioid receptors in the inhibitory effects induced by sacral dorsal root ganglion stimulation on nociceptive and nonnociceptive conditions in cats. Neurourol Urodyn 37(8):2462–2469CrossRefPubMed
Metadaten
Titel
Efficacy of a novel wearable transcutaneous tibial nerve stimulation device on bladder reflex compared to implantable tibial nerve stimulation in cats
verfasst von
Xunhua Li
Zhonghan Zhou
Hui Zhao
Limin Liao
Xing Li
Publikationsdatum
19.12.2022
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2023
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-022-03450-8

Weitere Artikel der Ausgabe 4/2023

International Urology and Nephrology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.